Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Have $1,000? This Beaten-Down Biotech Has 4 Phase 3 Obesity Trials Underway.

Even a small share of the massive market for weight loss drugs could lead to a significant increase in this company's share price.

We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Every outlet that reported this, and when →

Read the original at fool.com →

More in Health & Medicine

More from Wednesday 18 November →